Articles Posted in Mass Tort

Philadelphia personal injury law firm Anapol Weiss was given a Tier 1 ranking in the 2015 edition of Best Law Firms. The publication created by U.S. News & World Report and Best Lawyers named the firm among the best for the category of Plaintiffs’ Mass Tort Litigation and Class Actions both nationally and in Philadelphia. The firm also received the highest ranking in Philadelphia for the category of Plaintiffs’ Personal Injury Litigation.

The recognition further exemplifies how the Pennsylvania personal injury attorneys at Anapol Weiss are leaders in personal injury law as a well as mass tort and class action lawsuits. The firm’s Shareholders have held various leadership positions throughout their legal careers. For example, Sol Weiss currently serves as Co-Lead Counsel in the National Football League Players’ Concussion Injury Litigation and is among the Lead Class Counsel in Kids for Cash civil rights litigation. Best Lawyers also named Weiss 2014 Lawyer of the Year in Mass Tort Litigation and Class Actions. Thomas Anapol is Co-Lead Counsel in the Biomet Metal-on-Metal Hip Implant Litigation in addition to serving in many other leadership roles in medical device litigation. Gregory Spizer is Co-Lead Counsel in the In re: Mirena Litigation, and he was appointed to the Plaintiff’s Steering Committee in the Testosterone multidistrict litigation.

To be considered for Best Law firms, at least one attorney from the firm must be selected for inclusion in Best Lawyers in the corresponding year. Sol Weiss, James Ronca, and Lawrence Cohan were named in the 2015 edition of Best Lawyers Philadelphia. Ronca was also named the top personal injury attorney in Philadelphia.

On June 16, the Philadelphia Trial Lawyers Association (PTLA) elected Lawrence Cohan of Anapol Weiss as the new President of the organization.

For more than 50 years, PTLA has sought to protect the rights of all individuals, and it has become a growing force in the community. The organization is made up of more than 1,000 trial lawyers who aim to preserve the legal system and create new laws to protect the rights of the community.

“Because of the Trial Lawyers, the workplace in Pennsylvania is safer,” Cohan said. “Products are safer because manufacturers know we hold them responsible, and perhaps we have also helped make it safer to be a patient in a hospital in Pennsylvania.”

Modern Medicine has come a long way. The Pharmaceutical Industry as we know it began in 1928 when Sir Alexander Fleming discovered Penicillin. The discovery of this antibiotic from the mould, Penicillium notatum, was stated by Time Magazine as the discovery that would change the course of history. This infection-fighting antibiotic inspired other scientists to produce their own synthetic versions of this drug that would go on to treat some of the most common and serious infections and diseases known to mankind.

Since 1994, the Biotechnology Company, LifeCell, has been a pioneer in regenerative medicine. Their success can be attributed to rising sales of their flagship product, AlloDerm.
AlloDerm Regenerative Tissue Matrix, is an Accellular Human Dermis, which is an organic tissue graft produced through a unique non-damaging process that allows the body to mount its own tissue regeneration process. Essentially, the skin, which is derived from cadavers, goes through a process to remove all off the epidermis and dermis skin layers leaving only the collagen and elastin framework of the skin. This process removes that elements of the skin that would ordinarily be rejected by the recipient leaving only what will be accepted by the new body, and ultimately assist in the cellular rebuilding process.

In 1994 AlloDerm was originally developed and used for grafts for burn patients. In the early 2000s it began being marketed for internal procedures. Currently, AlloDerm’s most common uses include hernia repair, abdominal wall reconstruction, and postmasectomy breast reconstruction. AlloDerm is also used by dentists for soft tissue and gum reconstruction.
As stated on LifeCell’s website. AlloDerm has been used successfully in more than one million grafts and implants to date. However, nothing is perfect, and it is impossible to measure success without acknowledging failures.
Continue Reading

Put it on your calendars, Anapol Weiss attorney James Ronca will be speaking on “Topamax: What You Need to Know, The Science and the Litigation” from 10:45 am to 11:15 am at the semi-annual Mass Torts Made Perfect Seminar in Las Vegas, Nevada on October 13, 2011. The acclaimed national event for Pharmaceutical and Medical Device Mass Torts will celebrate its 10th anniversary at The Bellagio Hotel and Casino in Las Vegas.

Mr. Ronca is a vital part of Anapol Weiss Dangerous Drug and Medical Device team and is intimately involved with Topamax litigation along with partner Sol Weiss, who is co-liaison counsel to the coordinated litigation. You can register for the event online here or by calling (800) 320-2227. The cost of registration is $1,395 for lawyers and $995 for paralegals or administrators for firms; a $300 discount is obtainable for all affiliates of The National Trial Lawyers.

Mass torts can be separated from other kinds of personal injury cases by numerous key attributes. For one, they employ large amounts of claims that correspond to one product. Secondly, regardless of the large number of individuals involved, there is a similar nature to the facts and legal implications of the cases. Thirdly, there is interconnectedness between all the separate cases. Such is the case with Topamax, a drug used to treat epileptic seizures and other disorders that has also been linked to causing birth defects. If you’ve been injured by Topamax or another dangerous drug, call 1-866-735-2792 to contact the Pennsylvania dangerous drug attorneys at Anapol Weiss today.

Contact Information